AlphaCore Capital »

Halozyme Therapeutics shares owned by AlphaCore Capital

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by AlphaCore Capital from 13F filings

Historical chart of AlphaCore Capital investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by AlphaCore Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by AlphaCore Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.0M 41k 73.34
2025-06-30 $2.1M 41k 52.02
2025-03-31 $2.4M 38k 63.81

More positions owned by AlphaCore Capital

Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Meta Platforms Cl A (META)
Schwab Strategic Tr Fundamental Us L (FNDX)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
MPLX Com Unit Rep Ltd (MPLX)
Schwab Strategic Tr Fundamental Intl (FNDF)
Ishares Tr Core Msci Total (IXUS)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Etf Ser Solutions Distillate Us (DSTL)
Ishares Tr Russell 3000 Etf (IWV)
Apple (AAPL)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)

View all positions for AlphaCore Capital

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Arrowstreet Capital, Limited Partnership
Invesco
UBS Group
Snyder Capital Management
D. E. Shaw & Co
Geode Capital Management
Dimensional Fund Advisors
Alliancebernstein
Morgan Stanley
Macquarie Group
Federated Investors
Congress Asset Management

View all funds holding Halozyme Therapeutics